Research Article

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis

Figure 4

Validation of risk signatures of NOL12-related genes in the training and testing cohorts. (a, b) Distribution of risk score, survival status, and gene expression among patients in the training and testing cohorts. (c, d) The Kaplan–Meier curves of the high-risk and low-risk groups in the training and testing cohorts were compared. (e, f) ROC curves showing the predictive efficiency of the risk score for the 1-year, 3-year, and 5-year survival rate in the training and testing cohorts. (g, h) Univariate Cox regression analysis of prognostic factors in the training and testing cohorts.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)